March 16, 2015 by Dan • Commentary

Shares of Facebook (FB) have been stuck between $74 and $82 for the better part of the last six months and importantly have not confirmed a new high in the S&P 500 since late last …

Continue reading
March 13, 2015 by Dan • Commentary

Yesterday I highlighted the relative under-performance of Bank Of America (BAC) to its moneycenter bank peers Citibank (C) and JP Morgan (JPM) given the company’s second consecutive request to resubmit their capital return plan following …

Continue reading
March 10, 2015 by Dan • Commentary

The Biotech sector has been a massive out-performer over the last year, with the IBB (iShares Nasdaq Biotech etf) up 13% in 2015, and up 65% since from the 52 week lows made in April of last …

Continue reading
March 4, 2015 by Dan • Commentary

For the last few weeks CRM had been on our radar as a technical breakout candidate (here) as the market rally appeared to be broadening out with the Russell 2000 making new highs. Last week …

Continue reading
March 26, 2014 by Dan • Commentary

Back on February 27th I wanted to take a bullish view on GE with the idea that the stock’s underperformance since reporting their Q4 would abate and the stock would play catch up with the …

Continue reading
March 25, 2014 by Enis • Commentary

Facebook has bounced so far today after an ugly breakdown to its 50 day moving average yesterday.  We received a question on our thoughts for our April 65/60/55 put butterfly (post included below) that Dan …

Continue reading